4FMFES and FDG-PET of a ER+ uterine cancer mouse xenograft model

Conclusions: 4FMFES-PET enables detection of RL95-2 ER+ uterine tumors in a xenografted mouse model with a similar contrast as with FDG-PET. Preclinical data obtained foretell the feasibility of 4FMFES imaging for clinical uterine cancer applications. Orthotopic mouse models for both uterine and ovarian cancers are under development and will be evaluated in the near future.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Paquette, M., Phoenix, S., Lecomte, R., Guerin, B., Turcotte, A. t. Tags: Oncology, Basic and Translational (Basic Science) Posters Source Type: research